The Overloaded MSL: Why The Role Is Busier Than EVER

In this episode, Tom Caravela and Kirsten Gostomski discuss the evolving challenges and future of the Medical Science Liaison (MSL) role. They explore the increased workload and the shift from qualitative to quantitative metrics, along with the implications of the "super reps" concept. The conversation examines how company size affects MSL responsibilities and the challenges of accessing Key Opinion Leaders (KOLs). They explore the role of AI in reducing administrative burdens and offer strategies for organization and prioritization. Balancing professional duties with parenthood is also addressed. The episode concludes with predictions for the future of the MSL role, advice for overwhelmed MSLs, and tips on setting boundaries. (0:00) Introduction and Kirsten Gostomski's background (1:32) Sponsor: Fierce Pharma Week (2:45) Increased workload for MSLs and evolving role challenges (4:51) Shift from qualitative to quantitative MSL metrics (7:49) "Super reps" concept and implications for MSLs (9:39) Future of MSL roles and overlap with commercial roles (12:03) Company size impact on MSL workload and responsibilities (13:24) KOL access challenges and strategic planning (15:10) Role of AI in reducing MSL administrative burdens (16:43) Organization and prioritization strategies for MSLs (18:25) Balancing MSL work with parenthood (21:14) Predictions for the future of the MSL role (23:20) Advice for overwhelmed MSLs and maintaining performance (25:38) Final advice, setting boundaries, and closing remarks